Perkhofer et al. (2017) also revealed that ATM deletion causes pancreatic ductal adenocarcinomas genome instability and sensitizes this cancer to therapeutics inducing DNA damaging agents [31]. The gene discussed is ATM; the disease is pancreatic ductal adenocarcinoma.